HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early Blood Lactate as a Biomarker for Cardiovascular Collapse in Experimental Sepsis.

AbstractABSTRACT:
Cecal ligation and puncture (CLP) is the gold standard model for studying septic shock which is characterized by hypotension and hyporeactivity to vasoconstrictors. However, approximately 30% of CLP animals do not exhibit cardiovascular changes, requiring more replicates due to the high variability of the model. Therefore, biomarkers enabling the early prediction of cardiovascular collapse in sepsis would greatly benefit sepsis nonclinical studies, refining experimental models and improving clinical translation. Thus, this study aimed to test whether the early increase in lactate levels could predict hypotension and hyporesponsiveness to vasoconstrictors in a rat model of sepsis. Male and female Wistar rats were subjected to CLP or sham procedure. Tail blood lactate was measured 6, 12 and 24 hours after surgery. Then, inflammatory, biochemical, and hemodynamic parameters were evaluated. Rats subjected to CLP developed hypotension, hyporesponsiveness to vasoconstrictors, an intense inflammatory process, and increased plasma markers of organ dysfunction. By employing ROC curve analysis, we have established that a lactate value of 2.45 mmol/L can accurately discriminate between a rat exhibiting a normal vasoconstrictive response and a vasoplegic rat with 84% accuracy (AUC: 0.84, CI: 0.67-1.00). The sensitivity, which is the ability to identify the true positive rats, was 75% (CI: 41 - 95), and the true negative rate was 81% (CI: 57 - 93). Therefore, early measurement of lactate levels in sepsis could serve as a valuable biomarker for distinguishing vasoplegic rats from those exhibiting normal vasoconstrictive responses.
AuthorsThander Jacson Nunes Calente, Lucas Braga Albino, Junior Garcia de Oliveira, Gabrielle Delfrate, Regina Sordi, Fábio André Santos, Daniel Fernandes
JournalShock (Augusta, Ga.) (Shock) (Nov 16 2023) ISSN: 1540-0514 [Electronic] United States
PMID38010082 (Publication Type: Journal Article)
CopyrightCopyright © 2023 by the Shock Society.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: